DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Camidge DR, Bang Y-J, Kwak EL. et al
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Lancet Oncol 2012;
13 (10) 1011-1019
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.